INNA-1605

N/A

Report date: 2025/03/06 17:58:00
NME

Base Information

Drug NameINNA-1605
Drug Alias NameINNA1605INNA-1605
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloid differentiation primary response protein MyD88 inhibitors
TargetsMyeloid differentiation primary response protein MyD88
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Yinuo Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWuhan Yinuo Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A